Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Common Equity (2016 - 2025)

Historic Common Equity for Mesa Laboratories (MLAB) over the last 15 years, with Q4 2025 value amounting to $186.7 million.

  • Mesa Laboratories' Common Equity rose 1680.6% to $186.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $186.7 million, marking a year-over-year increase of 1680.6%. This contributed to the annual value of $159.8 million for FY2025, which is 992.96% up from last year.
  • Per Mesa Laboratories' latest filing, its Common Equity stood at $186.7 million for Q4 2025, which was up 1680.6% from $178.5 million recorded in Q3 2025.
  • Mesa Laboratories' Common Equity's 5-year high stood at $406.2 million during Q1 2021, with a 5-year trough of $145.4 million in Q1 2024.
  • In the last 5 years, Mesa Laboratories' Common Equity had a median value of $383.8 million in 2022 and averaged $301.2 million.
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 8463.77% in 2021, then tumbled by 6304.95% in 2024.
  • Over the past 5 years, Mesa Laboratories' Common Equity (Quarter) stood at $396.3 million in 2021, then dropped by 2.3% to $387.2 million in 2022, then rose by 4.07% to $403.0 million in 2023, then tumbled by 60.34% to $159.8 million in 2024, then rose by 16.81% to $186.7 million in 2025.
  • Its Common Equity stands at $186.7 million for Q4 2025, versus $178.5 million for Q3 2025 and $172.5 million for Q2 2025.